Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Celecoxib products are in shortage in Canada (1 of 31 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An anti-inflammatory (COX-2 NSAID) used to relieve arthritis pain and inflammation.
Products affected
1 / 31
In shortage since
Feb 17, 2021
Reports on file
117
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
ACT CELECOXIB
200MG · CAPSULE · TEVA CANADA LIMITED
DIN 02420163 · since Feb 17, 2021, no end estimate · Item is to be discontinued
Resolved
M-CELECOXIB
100MG · CAPSULE · MANTRA PHARMA INC
DIN 02495465 · ended Jun 22, 2026 · Delay in shipping of the drug.
Resolved
AURO-CELECOXIB
100MG · CAPSULE · AURO PHARMA INC
DIN 02445670 · ended Jun 1, 2025 · Demand increase for the drug.
Resolved
PMSC-CELECOXIB
100MG · CAPSULE · PHARMASCIENCE INC
DIN 02517116 · ended May 20, 2025 · Disruption of the manufacture of the drug.
Avoided
CELECOXIB
100MG · CAPSULE · SANIS HEALTH INC
DIN 02436299 · ended Feb 10, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-CELECOXIB
100MG · CAPSULE · APOTEX INC
DIN 02418932 · ended Jan 23, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-CELECOXIB
200MG · CAPSULE · APOTEX INC
DIN 02418940 · ended Dec 12, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-CELECOXIB
100MG · CAPSULE · APOTEX INC
DIN 02418932 · ended Nov 21, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-CELECOXIB
100MG · CAPSULE · APOTEX INC
DIN 02418932 · ended Aug 8, 2024 · Disruption of the manufacture of the drug.
Resolved
AURO-CELECOXIB
100MG · CAPSULE · AURO PHARMA INC
DIN 02445670 · ended Jul 29, 2024 · Demand increase for the drug.
Resolved
AURO-CELECOXIB
200MG · CAPSULE · AURO PHARMA INC
DIN 02445689 · ended Jun 28, 2024 · Demand increase for the drug.
Resolved
AURO-CELECOXIB
100MG · CAPSULE · AURO PHARMA INC
DIN 02445670 · ended Mar 27, 2024 · Demand increase for the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Celecoxib is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.
The reported cause is: item is to be discontinued. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Celecoxib is classified under “ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS” (ATC M01AH).
Recent changes
No changes recorded yet.
Common questions
What is Celecoxib used for?
An anti-inflammatory (COX-2 NSAID) used to relieve arthritis pain and inflammation.
When will Celecoxib be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Celecoxib in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.